Live Well with Michelle

Market View: Growing concerns of crowded positioning,  Samsung's Foldable Bet, SK Hynix's IPO Frenzy & Singapore Stocks to Watch

10 min · 8 de jul de 2026
Portada del episodio Market View: Growing concerns of crowded positioning,  Samsung's Foldable Bet, SK Hynix's IPO Frenzy & Singapore Stocks to Watch

Descripción

Hosted by Michelle Martin, we unpack why AI stocks dragged global markets lower despite broader market resilience and what that signals for investors. We explore why the consumer discretionary sector has become Wall Street's biggest laggard - and whether it could be the market's next opportunity. In our UP or DOWN segment, we assess Samsung's bid to stay ahead of Apple in foldable smartphones and the overwhelming demand for SK Hynix's blockbuster US listing. Closer to home, we examine Singapore stocks in focus, including Frasers Property, ESR-REIT and Foundation Healthcare, and what their latest developments could mean for shareholders. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Live Well with Michelle!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

300 episodios

Portada del episodio LIVE WELL WITH MICHELLE: Beyond Willpower, The New Science of Weight Loss

LIVE WELL WITH MICHELLE: Beyond Willpower, The New Science of Weight Loss

Michelle speaks with the first Gastroenterologist in Singapore to be recognised as a National Fellow by World Obesity Federation, to find out about advances in weight control. As science transforms our understanding of obesity, experts now recognise it as a chronic disease shaped by biology, hormones and the brain - not just lifestyle choices. Hosted by Michelle Martin in conversation with Dr Ravishankar Asok-kumar, Senior Consultant, Gastroenterologist and Advanced Therapeutic Endoscopist at Singapore General Hospital, this episode explores why weight regain is so common, where GLP-1 medications and new minimally invasive treatments fit, and why personalised obesity care could change not just our weight, but our long-term health, confidence and quality of life.  See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Ayer24 min